Export 793 results:
Author Title [ Type(Desc)] Year
Filters: Keyword is Humans  [Clear All Filters]
Journal Article
T. E. Golde, Schneider, L. S., and Koo, E. H., Anti-aβ therapeutics in Alzheimer's disease: the need for a paradigm shift., Neuron, vol. 69, no. 2, pp. 203-13, 2011.
J. J. Gomar, Conejero-Goldberg, C., Davies, P., and Goldberg, T. E., Anti-Correlated Cerebrospinal Fluid Biomarker Trajectories in Preclinical Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 4, pp. 1085-97, 2016.
I. Liampas, Hatzimanolis, A., Siokas, V., Yannakoulia, M., Kosmidis, M. H., Sakka, P., Hadjigeorgiou, G. M., Scarmeas, N., and Dardiotis, E., Antihypertensive Medication Class and the Risk of Dementia and Cognitive Decline in Older Adults: A Secondary Analysis of the Prospective HELIAD Cohort., J Alzheimers Dis, vol. 89, no. 2, pp. 709-719, 2022.
S. A. Chau, Chung, J., Herrmann, N., Eizenman, M., and Lanctôt, K. L., Apathy and Attentional Biases in Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 3, pp. 837-46, 2016.
J. R. Burrell, Ballard, K. J., Halliday, G. M., and Hodges, J. R., Aphasia in Progressive Supranuclear Palsy: As Severe as Progressive Non-Fluent Aphasia., J Alzheimers Dis, vol. 61, no. 2, pp. 705-715, 2018.
J. C. Morris, Roe, C. M., Xiong, C., Fagan, A. M., Goate, A. M., Holtzman, D. M., and Mintun, M. A., APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging., Ann Neurol, vol. 67, no. 1, pp. 122-31, 2010.
M. Berger, Cooter, M., Roesler, A. S., Chung, S., Park, J., Modliszewski, J. L., VanDusen, K. W., J Thompson, W., Moseley, A., Devinney, M. J., Smani, S., Hall, A., Cai, V., Browndyke, J. N., Lutz, M. W., and Corcoran, D. L., APOE4 Copy Number-Dependent Proteomic Changes in the Cerebrospinal Fluid., J Alzheimers Dis, vol. 79, no. 2, pp. 511-530, 2021.
S. K. Singhrao, Harding, A., Chukkapalli, S., Olsen, I., Kesavalu, L., and Crean, S. J., Apolipoprotein E Related Co-Morbidities and Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 4, pp. 935-48, 2016.
Y. Ling Chai, Yeo, H. Kai- Hui, Wang, J., Hilal, S., Ikram, M. Kamran, Venketasubramanian, N., Wong, B. - S., and Chen, C. Li- Hsian, Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort., J Alzheimers Dis, vol. 51, no. 4, pp. 1111-8, 2016.
T. B. Shea and Remington, R., Apparent Cognitive Decline as Revealed by an Executive Function Test within a Cohort of Elderly Individuals Self-Reporting Normal Cognitive Performance., J Alzheimers Dis, vol. 61, no. 3, pp. 913-915, 2018.
H. - F. Wang, Tan, L., Cao, L., Zhu, X. - C., Jiang, T., Tan, M. - S., Liu, Y., Wang, C., Tsai, R. M., Jia, J. - P., and Yu, J. - T., Application of the IWG-2 Diagnostic Criteria for Alzheimer's Disease to the ADNI., J Alzheimers Dis, vol. 51, no. 1, pp. 227-36, 2016.
C. - C. Yang, Chiu, M. - J., Chen, T. - F., Chang, H. - L., Liu, B. - H., and Yang, S. - Y., Assay of Plasma Phosphorylated Tau Protein (Threonine 181) and Total Tau Protein in Early-Stage Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 4, pp. 1323-1332, 2018.
A. Lladó, Froelich, L., Khandker, R. K., Roset, M., Black, C. M., Lara, N., Chekani, F., and Ambegaonkar, B. M., Assessing the Progression of Alzheimer's Disease in Real-World Settings in Three European Countries., J Alzheimers Dis, vol. 80, no. 2, pp. 749-759, 2021.
S. Emrani, Libon, D. J., Lamar, M., Price, C. C., Jefferson, A. L., Gifford, K. A., Hohman, T. J., Nation, D. A., Delano-Wood, L., Jak, A., Bangen, K. J., Bondi, M. W., Brickman, A. M., Manly, J., Swenson, R., and Au, R., Assessing Working Memory in Mild Cognitive Impairment with Serial Order Recall., J Alzheimers Dis, vol. 61, no. 3, pp. 917-928, 2018.
J. L. Del-Aguila, Fernández, M. Victoria, Schindler, S., Ibanez, L., Deming, Y., Ma, S., Saef, B., Black, K., Budde, J., Norton, J., Chasse, R., Harari, O., Goate, A., Xiong, C., Morris, J. C., and Cruchaga, C., Assessment of the Genetic Architecture of Alzheimer's Disease Risk in Rate of Memory Decline., J Alzheimers Dis, vol. 62, no. 2, pp. 745-756, 2018.
K. Sugiyama, Tomata, Y., Kaiho, Y., Honkura, K., Sugawara, Y., and Tsuji, I., Association between Coffee Consumption and Incident Risk of Disabling Dementia in Elderly Japanese: The Ohsaki Cohort 2006 Study., J Alzheimers Dis, vol. 50, no. 2, pp. 491-500, 2016.
S. Liu, Dashper, S. G., and Zhao, R., Association Between Oral Bacteria and Alzheimer's Disease: A Systematic Review and Meta-Analysis., J Alzheimers Dis, vol. 91, no. 1, pp. 129-150, 2023.
M. Siotto, Simonelli, I., Pasqualetti, P., Mariani, S., Caprara, D., Bucossi, S., Ventriglia, M., Molinario, R., Antenucci, M., Rongioletti, M., Rossini, P. Maria, and Squitti, R., Association Between Serum Ceruloplasmin Specific Activity and Risk of Alzheimer's Disease., J Alzheimers Dis, vol. 50, no. 4, pp. 1181-9, 2016.
X. - X. Liu, Wu, P. - F., Liu, Y. - Z., Jiang, Y. - L., Wan, M. - D., Xiao, X. - W., Yang, Q. - J., Jiao, B., Liao, X. - X., Wang, J. - L., Liu, S. - H., Zhang, X., and Shen, L., Association Between Serum Vitamins and the Risk of Alzheimer's Disease in Chinese Population., J Alzheimers Dis, vol. 85, no. 2, pp. 829-836, 2022.
N. Kuriyama, Ozaki, E., Mizuno, T., Ihara, M., Mizuno, S., Koyama, T., Matsui, D., Watanabe, I., Akazawa, K., Takeda, K., Takada, A., Inaba, M., Yamada, S., Motoyama, K., Takeshita, W., Iwai, K., Hashiguchi, K., Kobayashi, D., Kondo, M., Tamura, A., Yamada, K., Nakagawa, M., and Watanabe, Y., Association between α-Klotho and Deep White Matter Lesions in the Brain: A Pilot Case Control Study Using Brain MRI., J Alzheimers Dis, vol. 61, no. 1, pp. 145-155, 2018.
S. Jong Chung, Chang, Y., Jeon, J., Shin, J. Il, Song, T. - J., and Kim, J., Association of Alzheimer's Disease with COVID-19 Susceptibility and Severe Complications: A Nationwide Cohort Study., J Alzheimers Dis, vol. 87, no. 2, pp. 701-710, 2022.
S. Vijayaraghavan, Darreh-Shori, T., Rongve, A., Berge, G., Sando, S. B., White, L. R., Auestad, B. H., Witoelar, A., Andreassen, O. A., Ulstein, I. D., and Aarsland, D., Association of Butyrylcholinesterase-K Allele and Apolipoprotein E ɛ4 Allele with Cognitive Decline in Dementia with Lewy Bodies and Alzheimer's Disease., J Alzheimers Dis, vol. 50, no. 2, pp. 567-76, 2016.
S. L. C. Geijselaers, Aalten, P., Ramakers, I. H. G. B., De Deyn, P. Paul, Heijboer, A. C., Koek, H. L., OldeRikkert, M. G. M., Papma, J. M., Reesink, F. E., Smits, L. L., Stehouwer, C. D. A., Teunissen, C. E., Verhey, F. R. J., van der Flier, W. M., and Biessels, G. Jan, Association of Cerebrospinal Fluid (CSF) Insulin with Cognitive Performance and CSF Biomarkers of Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 1, pp. 309-320, 2018.
S. J. Teipel, Dyrba, M., Ballarini, T., Brosseron, F., Bruno, D., Buerger, K., Cosma, N. - C., Dechent, P., Dobisch, L., Düzel, E., Ewers, M., Fliessbach, K., Haynes, J. D., Janowitz, D., Kilimann, I., Laske, C., Maier, F., Metzger, C. D., Munk, M. H., Peters, O., Pomara, N., Preis, L., Priller, J., Rámirez, A., Roy, N., Scheffler, K., Schneider, A., Schott, B. H., Spottke, A., Spruth, E. J., Wagner, M., Wiltfang, J., Jessen, F., and Heneka, M. T., Association of Cholinergic Basal Forebrain Volume and Functional Connectivity with Markers of Inflammatory Response in the Alzheimer's Disease Spectrum., J Alzheimers Dis, vol. 85, no. 3, pp. 1267-1282, 2022.
L. Wang, Davis, P. B., Volkow, N. D., Berger, N. A., Kaelber, D. C., and Xu, R., Association of COVID-19 with New-Onset Alzheimer's Disease., J Alzheimers Dis, vol. 89, no. 2, pp. 411-414, 2022.